A pivotal study is evaluating a non-evasive device, the Cardiac Performance System, (CPS), for pulmonary hypertension (PH) to reduce reliance on right heart catheterization. The study will compare the measurements obtained with the Cardiac Performance System with those obtained through right heart catheterization, the current gold-standard test used to measure pulmonary artery pressure.
If validated, this test could help clinicians distinguish between pulmonary hypertension subtypes more easily and safely, enabling earlier and more targeted treatment.
Source
Pulmonary Hypertension News, Lindsey Shapiro PhD, May 2, 2025
Read more at this link on Pulmonary Hypertension News.